Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis

References

• Enoch DA, Ludlam HA, Brown NM. Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 2006; 55: 809–818.
   PubMed Web of Science ®Google Scholar
• Antimicrobial Agents and Chemotherapy. New antimicrobial agents approved by the U.S. Food and Drug Administration in 2004 and new indications for previously approved agents. Antimicrob Agents Chemother 2005; 49: 2151.
   Google Scholar
• Antimicrobial Agents and Chemotherapy. New antimicrobial agents approved by the U.S. Food and Drug Administration in 2005 and new indications for previously approved agents. Antimicrob Agents Chemother 2006; 50: 1912.
   Google Scholar
• Antimicrobial Agents and Chemotherapy. New antimicrobial agents approved by the U.S. Food and Drug Administration in 2006 and new indications for previously approved agents. Antimicrob. Agents Chemother 2007; 51: 2649.
   Google Scholar
• Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695–1703.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005–2009). Rev Iberoam Micol 2009; 26: 15–22.
   PubMed Web of Science ®Google Scholar
• Kitamura A, Higuchi S, Hata M, . Effect of beta-1,6-glucan inhibitors on the invasion process of Candida albicans: potential mechanism of their in vivo efficacy. Antimicrob Agents Chemother 2009; 53: 3963–3971.
   PubMed Web of Science ®Google Scholar
• Kitamura A, Someya K, Hata M, Nakajima R, Takemura M. Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis. Antimicrob Agents Chemother 2009; 53: 670–677.
   PubMed Web of Science ®Google Scholar
• Chin NX, Weitzman I, Della-Latta P. In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother 1997; 41: 850–852.
   PubMed Web of Science ®Google Scholar
• Gyetvai A, Emri T, Takacs K, . Lovastatin possesses a fungistatic effect against Candida albicans, but does not trigger apoptosis in this opportunistic human pathogen. FEMS Yeast Res 2006; 6: 1140–1148.
   PubMed Web of Science ®Google Scholar
• Macreadie IG, Johnson G, Schlosser T, Macreadie PI. Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS Microbiol Lett 2006; 262: 9–13.
   PubMed Web of Science ®Google Scholar
• Song JL, Lyons CN, Holleman S, Oliver BG, White TC. Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans. Med Mycol 2003; 41: 417–425.
   PubMed Web of Science ®Google Scholar
• Westermeyer C, Macreadie IG. Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata. FEMS Yeast Res 2007; 7: 436–441.
   PubMed Web of Science ®Google Scholar
• Nyilasi I, Kocsube S, Krizsan K, . In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi. FEMS Microbiol Lett 2010; 307: 175–184.
   PubMed Web of Science ®Google Scholar
• Forrest GN, Kopack AM, Perencevich EN. Statins in candidemia: clinical outcomes from a matched cohort study. BMC Infect Dis 2010; 10: 152.
   PubMed Web of Science ®Google Scholar
• Navarathna DH, Hornby JM, Krishnan N, . Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect Immun 2007; 75: 1609–1618.
   PubMed Web of Science ®Google Scholar
• Hampton R, Dimster-Denk D, Rine J. The biology of HMG-CoA reductase: the pros of contra-regulation. Trends Biochem Sci 1996; 21: 140–145.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
   Google Scholar
• Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. Combination antifungal therapy. Antimicrob Agents Chemother 2004; 48: 693–715.
   PubMed Web of Science ®Google Scholar
• Hornby JM, Jensen EC, Lisec AD, . Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 2001; 67: 2982–2992.
   PubMed Web of Science ®Google Scholar
• Nash JD, Burgess DS, Talbert RL. Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans. J Med Microbiol 2002; 51: 105–109.
   PubMed Web of Science ®Google Scholar
• Mosel DD, Dumitru R, Hornby JM, Atkin AL, Nickerson KW. Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum. Appl Environ Microbiol 2005; 71: 4938–4940.
   PubMed Web of Science ®Google Scholar
• Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002; 68: 5459–5463.
   PubMed Web of Science ®Google Scholar
• Navarathna DHMLP, Hornby JM, Hoerrmann N, . Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. J Antimicrob Chemother 2005; 56: 1156–1159.
   PubMed Web of Science ®Google Scholar
• Komai T, Kawai K, Tokui T, . Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys. Eur J Drug Metab Pharmacokinet 1992; 17: 103–113.
   PubMed Web of Science ®Google Scholar
• Galgoczy L, Nyilasi I, Papp T, Vagvolgyi C. Are statins applicable for the prevention and treatment of zygomycosis? Clin Infect Dis 2009; 49: 483; author reply 484–485.
   PubMed Web of Science ®Google Scholar
• Gao F, Linhartova L, Johnston AM, Thickett DR. Statins and sepsis. Br J Anaesth 2008; 100: 288–298.
   PubMed Web of Science ®Google Scholar
• Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 2007; 7: 358–368.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Howe N, Volk K, . Candida albicans cell wall components and farnesol stimulate the expression of both inflammatory and regulatory cytokines in the murine RAW264.7 macrophage cell line. FEMS Immunol Med Microbiol 2010; 60: 63–73.
   PubMedGoogle Scholar